1.
Greening the Health Sector
Pharmaceuticals and
c
Climate Change
c c
Dr. Christoph Hamelmann
Regional Practice Leader HIV, Health and Development
UNDP Europe and Central Asia
CIS Pharmaceutical Forum
Moscow, Russia, 5 January 2013

2.
Likely Temperature Increase
by GHG Emission Pathways

3.
Energy Intensity
(Energy consumption per unit GDP 2011, ENERDATA)
Countries Energy Intensity World Major Country Ranking (highest 4)
Uzbekistan 0.633 1
Ukraine 0.436 2
Kazakhstan 0.399 3
Russia 0.346 4

4.
GHG Emission Reduction Pledges
CIS Countries
Countries Unconditional Pledge Conditional Pledge Current GHG Emissions
(MtCO2e 2010)
Armenia - Submitted policy actions 11
Azerbaijan - - 50
Belarus Reduction 8 % below 1990 level by 2020 - 150
Kazakhstan Reduction 15 % below 1990 level by 2020 - 318
Kyrgyzstan - - ?
Moldova Reduction 25 % below 1990 level by 2020 - 11
Russia Reduction 15 % below 1990 level by 2020 Reduction 25 % below 2510
1990 level by 2020
Tajikistan - Submitted policy actions 15
Uzbekistan - - 174
Turkmenistan - - 87
Ukraine Reduction 20 % below 1990 level by 2020 - 397

5.
Health Sector in the ECIS Region
• Accounts for 7.5 % of GDP
• Technology intensive with significant
consumption of resources, associated with
environmental pollution and degradation
• Accounts for an estimated 4.2 % of greenhouse
gases (GHG) in the ECIS region
• Up to 25 % of these GHG can be reduced within
short-term, more through long-term measures
• Reductions have also direct positive impact on
life-years saved
Ministerial European Environment and Health Task Force Meeting, Bled / Slovenia 2011

6.
NHS Carbon Footprint Breakdown 2010

7.
European Ministerial Environment & Health
Task Force
Fifth Ministerial Conference
on Environment and Health
Parma 2010
53 member states, including all
CIS countries
+ others

8.
Sector Guidance on Carbon Foot-Printing
• Cross-sectoral partnership
• Standardized quantification of
the GHG inventory of
pharmaceutical products
certified by international GHG
protocol
• Identification of hot spots
throughout the product life
cycle
• Focus on minimizing carbon
footprint for producers, buyers
and users of pharmaceutical
products http://www.sdu.nhs.uk/pharma-md

9.
Marginal Abatement Costs

10.
Gaining Efficiencies – Reducing GHG Emissions
Lessons Learnt From Pharma-Industry

11.
Stay competitive!

12.
ESA

13.
Economic Commission for Europe
Report Regional Preparatory Meeting
Public procurement
47. Sustainable public procurement was supported as a
first critical step to further the green economy at the
national as well as the sub-national level. Concrete
progress was proposed in the form of sustainable public
procurement targets that could be met by an increasing
number of countries over the years.

14.
Leadership and Innovations

15.
Thank You!
christoph.hamelmann@undp.org
Twitter: @cahamelmann